SN.L vs ZBH
SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions. ZBH: A global leader in musculoskeletal healthcare, providing a comprehensive portfolio of reconstructive implants, sports medicine, and trauma technologies to restore patient mobility.
Side-by-side fundamentals
| Metric | SN.L | ZBH | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £11.97 | $98.16 | |
| Market cap as of 2026-08-06 | n/a | $19.0B | |
| P/E as of 2026-08-06 | n/a | 24.36 | |
| PEG as of 2026-08-06 | n/a | 4.54 | |
| Net margin as of 2026-08-06 | n/a | +9.1% | |
| Gross margin as of 2026-08-06 | n/a | +70.0% | |
| Operating margin as of 2026-08-06 | n/a | +14.0% | |
| ROE as of 2026-08-06 | n/a | +6.0% | |
| ROA as of 2026-08-06 | n/a | +3.3% | |
| Debt / equity as of 2026-08-06 | n/a | 0.59 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +9.2% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +5.9% | |
| Dividend yield as of 2026-08-06 | n/a | +1.0% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-06 | n/a | 0.47 | |
| 1-year return as of 2026-08-03 close | +3.5% | +6.6% | ZBH higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.